首页> 外国专利> Haemodialysis monitoring system for haemodialysis machines

Haemodialysis monitoring system for haemodialysis machines

机译:血液透析机的血液透析监测系统

摘要

An improved on-line, real time hemodialysis monitoring system for hemodialysis treatment, quantitates the rate and amount of a constituent, such as urea, removed during the hemodialysis treating by measuring the constituent concentrations as a function of time in the spent dialysate effluent from a hemodialysis machine. A quantity of the spent dialysate effluent is removed from the dialysate effluent waste line periodically for testing. A urea concentration time profile can be analyzed to determine the urea removal, KT/V, URR, SRI, and normalized protein catabolic rate (nPCR) indices. The hemodialysis monitoring system preferably can obtain a dialysate sample equilibrated with the blood prior to the start of a hemodialysis treatment. In a further aspect of the hemodialysis monitoring system includes a device for conducting two-pool analysis for taking into account the constituent concentration differences in the extracellular and intracellular spaces in the hemodialysis patient during the hemodialysis treatment to determine the intercompartmental transfer coefficient KI of a patient, which allows more precise adjustment of the hemodialysis prescription for the patient.
机译:一种经过改进的在线实时血液透析监测系统,用于血液透析治疗,通过测量血液透析液中透析液废液中浓度随时间的变化来定量血液透析治疗期间去除的成分(如尿素)的速率和数量。血液透析机。定期从透析液废液排放管线中除去一定量的废透析液以进行测试。可以分析尿素浓度时间曲线以确定尿素去除率,KT / V,URR,SRI和归一化蛋白质分解代谢速率(nPCR)指标。血液透析监测系统优选地可以在开始血液透析治疗之前获得与血液平衡的透析液样品。血液透析监测系统的另一方面包括用于进行两池分析的装置,以考虑到血液透析治疗期间血液透析患者中​​细胞外和细胞内空间的成分浓度差异,以确定患者的房间转移系数KI ,可以更精确地调整患者的血液透析处方。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号